Freyr helps brands stay ahead with dossier preparation, algorithm navigation, design compliance, and global labeling strategy
Lcarnitine supplementation to reverse hyperammonemia in a patient undergoing chronic valproic acid treatment: a case report
Lillys Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease 2025 [Press release]
Harvard Kumar Malesu, Vijay
In December 2023, Hansoh released the initial data of the phase 1 study: Following a single dose of HS-20094, the median Tmax ranged from 8 to 48h
The decision regarding tirzepatide management should be made collaboratively between the surgical team, anesthesiologist, and prescribing physician